drugset / Trial / NCT01487499

Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)

NCT01487499 ↗

Phase 3 Terminated 4 enrolled University of Florida
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This project proposes to use bronchoscopic intratumoral chemotherapy for small cell lung cancer in two fashions: 1. to implement a prospective clinical trial to test the feasibility and efficacy of intralesional chemotherapy as consolidative therapy immediately following standard systemic chemotherapy and radiation therapy for patients with limited stage SCLC by comparing tumor growth and survival rates of the treatment group and compare the outcomes to historical controls 2. to implement a prospective clinical trial to test the feasibility and efficacy as measured by tumor growth and survival rates of intralesional chemotherapy for patients with recurrent SCLC after standard treatment.

Timeline

Start
2011-12
Primary completion
2015-03
Completion
2015-03

Outcome

Outcome not reported

Stopped (Enrollment): “Unable to enroll adequate number of participants”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 40 mg Other